Sernova Biotherapeutics (OTCMKTS:SEOVF) Announces Earnings Results

Sernova Biotherapeutics (OTCMKTS:SEOVF) announced its quarterly earnings data on Thursday. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.01), Zacks reports.

Sernova Biotherapeutics Stock Performance

Shares of SEOVF stock opened at $0.11 on Friday. Sernova Biotherapeutics has a 52-week low of $0.09 and a 52-week high of $0.16. The stock has a market cap of $42.30 million, a PE ratio of -2.80 and a beta of 0.82. The firm’s 50 day moving average price is $0.12 and its two-hundred day moving average price is $0.11.

About Sernova Biotherapeutics

Sernova Biotherapeutics is a clinical‐stage biotechnology company focused on developing and commercializing cell‐based therapeutic technologies for patients with chronic and life‐threatening diseases. Headquartered in London, Ontario, Canada, the firm is advancing an implantable device platform designed to support the long-term survival and function of therapeutic cells. The company’s lead product candidate, known as the Cell Pouch System, is engineered to create a vascularized environment in which transplanted cells can thrive, with an initial emphasis on treating patients with type 1 diabetes.

In its core program, Sernova has initiated a Phase I/II clinical trial evaluating the safety and efficacy of the Cell Pouch System in individuals with type 1 diabetes who require islet cell transplantation.